UNSPSC 85816109: Introduction of insulin into peripheral artery, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of insulin into peripheral artery, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E053VG

UNSPSC 85816109 Introduction of insulin into peripheral artery, percutaneous approach (Commodity) shows minimal recent activity aligned with its clinical scope. The code nominally describes a specific percutaneous insulin administration procedure, but recent state and local solicitations tagged under this code diverge sharply from that description. Instead, the opportunities posted involve virtual urgent care services, generic medical services, comprehensive PACE operations, rural value-based care facilitation, cancer registry services, retinal screening devices, EMT staffing, employee health clinics, occupational health and wellness, travel nursing, medical director roles, psychological evaluations, and opioid treatment—none of which match the narrow procedural scope implied by the code name. The issuing bodies span state health authorities (Nevada, Texas), counties (DeKalb, Boulder, Forsyth, Cobb, Seminole, Ventura), cities (San Mateo, Ocala, Phoenix, Chicago, Atlanta), school districts (Parkway), and regional authorities (Santa Clara County Health System, Harris County), indicating broad state and local healthcare procurement interest, though not specifically in insulin administration procedures.

Recent opportunities cluster across California, Nevada, Georgia, Florida, Colorado, and Arizona, with additional activity in Kansas, Texas, and the District of Columbia. Representative recent solicitations include the Nevada Health Authority requesting proposals for Program of All Inclusive Care for the Elderly (PACE) operations with an RFP response due December 10, 2026, and San Mateo County requesting cancer registry services with an RFP due November 6, 2026. The source does not support any current procurement activity specifically targeting insulin infusion or percutaneous vascular access procedures; the code's assignment to these opportunities appears to reflect miscategorization by issuing bodies rather than genuine demand for the procedure itself. If your firm specializes in insulin delivery devices, percutaneous vascular access, or related endovascular technologies, this code shows no relevant recent opportunity flow and warrants monitoring only; if you work in healthcare operations, staffing, or program administration, the underlying opportunities are active and geographically dispersed across the South, West, and Mid-Atlantic regions, though they are not correctly tagged to this specific commodity code.